Simple and rapid analysis of Linagliptin in dried blood spot using an ionic liquid based vortex‐assisted dispersive liquid–liquid microextraction coupled with liquid chromatography–electrospray ionization–tandem mass spectrometry: Application to pharmacokinetic studies-Reference-Cited by-同舟云学术

Simple and rapid analysis of Linagliptin in dried blood spot using an ionic liquid based vortex‐assisted dispersive liquid–liquid microextraction coupled with liquid chromatography–electrospray ionization–tandem mass spectrometry: Application to pharmacokinetic studies

Published:2021-07-08 Issue:9 Volume:4 Page:328-336
ISSN:2573-1815
Container-title:SEPARATION SCIENCE PLUS
language:en
Short-container-title:Sep Sci plus

Author:

Arnipalli Manikanta Swamy¹,Nimmu Narendra Varma¹^ORCID,Bondigalla Ramachandra²,Challa Gangu Naidu³^ORCID

Affiliation:

1. Discovery Lab Analytical Chemistry Division Indian Institute of Chemical Technology Tarnaka Hyderabad India

2. Government College for Men Kadapa Andhra Pradesh India

3. Vignan's Foundation For Science Technology & Research (VFSTRU) (Deemed to be University) Vadlamudi Guntur Andhra Pradesh India

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sscp.202100008

Reference27 articles.

1. The Metabolism and Disposition of the Oral Dipeptidyl Peptidase-4 Inhibitor, Linagliptin, in Humans

2. The Role of DPP-4 Inhibitors in the Treatment Algorithm of Type 2 Diabetes Mellitus: When to Select, What to Expect

3. Truncation of Macrophage-derived Chemokine by CD26/ Dipeptidyl-Peptidase IV beyond Its Predicted Cleavage Site Affects Chemotactic Activity and CC Chemokine Receptor 4 Interaction

4. Excretion of the dipeptidyl peptidase-4 inhibitor linagliptin in rats is primarily by biliary excretion and P-gp-mediated efflux

5. Efficacy and safety of linagliptin in subjects with type 2 diabetes mellitus and poor glycemic control: Pooled analysis of data from three placebo-controlled phase III trials